References
- Alm K, Berntsson PS, Kramer DL, Porter CW, Oredsson SM. 2000. Treatment of cells with the polyamine analog N, N11-diethylnorspermine retards S phase progression within one cell cycle. European Journal of Biochemistry 267:4157–4164.
- Bergeron RJ, Wiegand J, McManis JS, Weimar JR, Smith RE, Algee SE, Fannin TL, Slusher MA, Snyder PS. 2001. Polyamine analogue antidiarrheals: A structure- activity study. Journal of Medicinal Chemistry 44:232–244.
- Copp RR, Peebles DD, Fahl WE. 2011. Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors. Bioorganic and Medicinal Chemistry Letters 21: 7426–7430.
- Fahl WE, Peebles DD, Copp RR. 2007. Amino thiol compounds and compositions for use in conjunction with cancer therapy. U.S. patent 7,314,959. See http://patft.uspto.gov
- Feuerstein BG, Pattabiraman N, Marton LJ. 1990. Molecular mechanics of the interactions of spermine with DNA:DNA bending as a result of ligand binding. Nucleic Acids Research 18:1271–1282.
- Feuerstein BG, Williams LD, Basu HS, Marton LJ. 1991. Implications and concepts of polyamine-nucleic acid interactions. Journal of Cellular Biochemistry 46:37–47.
- Grdina DJ, Shigematsu N, Dale P, Newton GL, Aguilera AJ, Fahey RC. 1995. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action. Carcinogenesis 16:767–774.
- Kramer DL, Fogel-Petrovic M, Diegelman P, Cooley JM, Bernacki RJ, McManis JS, Bergeron RJ, Porter CW. 1997. Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Research 57: 5521–5527.
- Marton LJ, Pegg AE. 1995. Polyamines as targets for therapeutic intervention. Annual Review of Pharmacology and Toxicology 35: 55–91.
- Patt HM, Tyree EB, Straube RL, Smith DE. 1949. Cysteine protection against X irradiation. Science 110:213–214.
- Peebles DD, Soref CM, Copp RR, Fahl WE. 2012. ROS-scavenger and radioprotective efficacy of the new PrC-210 aminothiol. Radiation Research 178:57–68.
- Pegg AE. 2008. Spermidine/spermine-N(1)-acetyltransferase: A key metabolic regulator. American Journal of Physiology, Endocrinology and Metabolism 294:995–1010.
- Rose PG. 1996. Amifostine cytoprotection with chemotherapy for advanced ovarian carcinoma. Seminars in Oncology 23 (4 Suppl.): 83–89.
- Saminathan M, Antony T, Shirahata A, Sigal LH, Thomas T, Thomas TJ. 1999. Ionic and structural specificity effects of natural and synthetic polyamines on the aggregation and resolubilization of single-, double-, and triple-stranded DNA. Biochemistry 38:3821–3830.
- Soref CM, Hacker TA, Fahl WE. 2012. A new aminothiol radioprotector free of nausea and hypotension side effects at high radioprotective doses. International Journal of Radiation Oncology, Biology and Physics 82:701–707.
- Spotheim-Maurizot M, Ruiz S, Sabattier R, Charlier M. 1995. Radioprotection of DNA by polyamines. International Journal of Radiation Biology 68:571–577.
- Stevens CW, Brondyk WH, Burgess JA, Manoharan TH, Haene BG, Fahl WE. 1988. Partially transformed, anchorage-independent human diploid fibroblasts result from overexpression of the c-sis oncogene: Mitogenic activity of an apparent monomeric Platelet-Derived Growth Factor 2 species. Molecular and Cellular Biology 85:2089–2096.
- Weiss, JF. 1997. Pharmacologic approaches to protection against radiation-induced lethality and other damage. Envir Hlth Perspect 105: 1473–1478.
- Yarlett N, Wu G, Waters WR, Harp JA, Wannemuehler MJ, Morada M, Athanasopoulos D, Martinez MP, Upton SJ, Marton LJ, Frydman BJ. 2007. Cryptosporidium parvum spermidine/spermine N1-acetyltransferase exhibits different characteristics from the host enzyme. Molecular Biochemistry and Parasitology 152:170–180.